眼植入剂是一种长效定量缓释的新型药物制剂 ,适用于需要长期治疗的多种眼科慢性疾患、眼外伤和眼科手术并发症。本文简要介绍了眼植入剂在预防和治疗白内障摘出术后炎症反应和后囊浑浊、青光眼滤过泡术后瘢痕化、角膜移植排斥反应等术后并发症及角膜血管新生、巨细胞病毒性视网膜炎、增生性玻璃体视网膜病变、慢性葡萄膜炎等眼科疾患中的研究进展 Eye implants are a new type of long-acting, sustained-release drug for long-term treatment of a variety of chronic ophthalmic conditions, ocular trauma and ophthalmic surgical complications. This article briefly introduced the ocular implants in the prevention and treatment of cataract extraction after inflammation and posterior capsule opacification, glaucoma filtering bleb scarring, corneal graft rejection and other postoperative complications and corneal neovascularization, cytomegalovirus Retinal inflammation, proliferative vitreoretinopathy, chronic uveitis and other ophthalmic disorders in the research progress